Table 1 Baseline characteristics of patients
|  | Normal (n = 2176) | CKD (n = 1129) | p value |
|---|---|---|---|
Female, n | 709 (32.6) | 535 (47.4) | 0.001 |
Age, years | 63.7 (58.0–71.0) | 75.0 (71.0–80.0) | 0.001 |
Weight, kg | 69.8 ± 11.0 | 59.7 ± 10.0 | 0.001 |
BMI, kg/m2 | 25.4 ± 3.2 | 23.2 ± 3.2 | 0.001 |
eGFR, mL min−1 1.73 m−2 | 85.5 (69.5–95.1) | 44.5 (39.0–54.0) | 0.001 |
Paroxysmal AF | 1463 (67.2) | 722 (64.0) | 0.067 |
Persistent AF | 612 (28.1) | 346 (30.6) | 0.067 |
Permanent AF | 101 (4.6) | 61 (5.4) | 0.067 |
CHA2DS2-VASc score | 2.3 (1.0–3.0) | 3.7 (3.0–5.0) | 0.001 |
HAS-BLED score | 1.7 (1.0–2.0) | 2.4 (2.0–3.0) | 0.001 |
Heart failure | 186 (8.5) | 188 (16.7) | 0.001 |
Hypertension | 1407 (64.7) | 863 (76.4) | 0.001 |
Diabetes mellitus | 516 (23.7) | 378 (33.5) | 0.001 |
Stroke/TIA | 309 (14.3) | 250 (22.2) | 0.001 |
Myocardial infarction | 76 (3.5) | 55 (4.9) | 0.054 |
PAD | 98 (4.5) | 77 (6.8) | 0.009 |
History of bleeding | 217 (10.0) | 155 (13.7) | 0.43 |
ICD insertion | 27 (1.2) | 16 (1.4) | 0.671 |
Pacemaker insertion | 98 (4.5) | 128 (11.3) | 0.001 |
Dyslipidemia | 743 (34.1) | 404 (35.8) | 0.348 |
Cancer | 203 (9.3) | 130 (11.5) | 0.048 |
LA volume, mL/m2 | 53.9 ± 29.0 | 68.4 ± 40.4 | 0.001 |
LVEF, % | 60.2 ± 20.2 | 58.6 ± 9.6 | 0.149 |
Follow-up duration, months | 10.5 (9.5–12.3) | 10.7 (9.5–12.3) | 0.051 |